Mr Krzysztof Zieba > Kochanski & Partners > Warsaw, Poland > Lawyer Profile

Kochanski & Partners
METROPOLITAN BUILDING
PL PILSUDSKIEGO 1
00-078 WARSAW
Poland

Work Department

FMCG Law Practice, Retail & Automotive Law Practice, Trade & Distribution Law Practice

Position

Partner, Head of FMCG, Retail & Automotive and Trade & Distribution Law Practices

Career

Krzysztof is specialized in issues related to marketing, commercial law, e-commerce and the formation of distribution systems. He has a wide range of experience in regard to the preparation and negotiation of trade agreements, including those which form a basis for the operations of supply chains (including commercial networks) and distribution agreements (including franchising systems and systems of selective distribution).

For many years Krzysztof has dealt with matters pertaining to consumer law and combating unfair competition (including, in particular, issues regarding so-called slotting fees).

He is also highly experienced in resolving domain name disputes, assisting clients to reclaim “cyber-squatted” internet domain names before the relevant dispute arbitration courts.

Apart from the pharmaceutical branch, Krzysztof also advises clients from the FMCG, chemical, food, cosmetics and automotive sectors.

Languages

Polish, English

Memberships

The Warsaw Bar of Legal Advisors

Education

The Jagiellonian University of Krakow (Master of Political Science, 2006 and Master of Law, 2007)

Lawyer Rankings

Poland > Healthcare and life sciences

Kochanski & Partners‘ practice is noted for handling a broad array of mandates, including trade mark infringement actions and allegations, and proceedings concerning tenders. The team is also known for its medtech expertise, advising on medical records management and cloud-based IT solutions. Noted for his specialism in marketing and the formation of distribution systems, Krzysztof Zięba leads the team, and often assists clients with the negotiation of trade and distribution agreements, as well as acting in pharmaceutical product marketing disputes.